12:00 AM
Oct 12, 2015
 |  BC Week In Review  |  Company News  |  Deals

Horizon Discovery, Abcam deal

Horizon granted Abcam exclusive rights to more than 1,800 diploid and haploid cell line models developed using Horizon’s X-MAN technology, which Abcam will use to validate the function of its antibodies....

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >